Chromium picolinate and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Chromium picolinate (chromium) and Abilify (aripiprazole). Common drug interactions include chest pain among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Chromium picolinate and Abilify. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Chromium picolinate?

Chromium picolinate has active ingredients of chromium. It is often used in weight loss. eHealthMe is studying from 1,205 Chromium picolinate users. Check the latest studies of Chromium picolinate.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

On Jul, 16, 2026

18 people who take Chromium picolinate and Abilify together, and have interactions are studied.

Chromium picolinate and Abilify drug interactions.

What are the common drug interactions of Chromium Picolinate and Abilify, by gender? *:

female:

Chest pain
Dizziness
Fall
Headache (pain in head)
Pain
Pain in extremity
Weight increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gingivitis (inflammation of gums)

male:

Dyspnoea (difficult or laboured respiration)
Overdose
Peripheral swelling
Drug hypersensitivity
Fracture nonunion (permanent failure of healing following a broken bone)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Chromium Picolinate and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Drug hypersensitivity
Malaise (a feeling of general discomfort or uneasiness)

50-59:

Burning sensation
Confusional state
Fall
Fracture nonunion (permanent failure of healing following a broken bone)
Laceration (tearing of soft body tissue)
Muscle spasms (muscle contraction)

60+:

Dyspnoea (difficult or laboured respiration)
Fall
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Contusion (a type of hematoma of tissue in which capillaries)
Crying
Dizziness
Gait disturbance
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gingivitis (inflammation of gums)
Headache (pain in head)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 61.11%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 27.78%
Bipolar Disorder (mood disorder): 4 people, 22.22%
Immunodeficiency Common Variable: 3 people, 16.67%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 5.56%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 5.56%
Blood Iron Decreased: 1 person, 5.56%
Blood Testosterone Decreased: 1 person, 5.56%
Diabetes: 1 person, 5.56%
Drug Dependence: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Chromium picolinate and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously